A new study from Aarhus University Hospital in Denmark has found that antidepressant drugs such as Zoloft and other selective serotonin reuptake inhibitors (SSRIs) increase the risk of bleeding in patients who have had a stroke. Researchers said the increased bleeding risk could be a factor in the increased number of deaths among ischemic stroke patients using Zoloft.
Zoloft side effects have been heavily researched in recent years due to an increased concern in the medical community. In particular, Zoloft birth defects have caused doctors to warn expectant mothers about the risks of using antidepressants during pregnancy.
Pfizer is facing several Zoloft lawsuits alleging that the company failed to warn patients about the increased risks of birth defects among children born to mothers who use the drug during pregnancy. Zoloft birth defects include persistent pulmonary hypertension of the newborn (PPHN), omphalocele, brain defects, heart defects and other congenital birth defects.